Twelve years of diagnostic wandering on average, disabling chronic pain, major impacts on fertility: endometriosis remains one of the most complex gynaecological conditions to manage. Faced with the limits of conventional treatments, a therapeutic innovation is emerging with Nutriend, a natural polymetallic complex showing significant clinical results. Does this advance transform your therapeutic approach?
Bringing Nutriend into your therapeutic arsenal
Having a natural, effective therapeutic solution for endometriosis considerably enriches your gynaecological expertise. Nutriend offers you a complementary alternative to hormonal treatments, particularly valued by patients seeking less invasive approaches.
This innovation from the brand Nutrilab meets an unmet medical need, positioning you at the forefront of integrative therapeutic solutions. Compatibility with fertility treatments further widens your options for personalised care.
Understanding the scale of the endometriosis challenge
Epidemiology and clinical impact
Endometriosis affects 1 to 2 women in 10 of reproductive age, representing approximately 180 to 190 million women worldwide. This considerable prevalence underlines the importance of optimising your management of this chronic condition.
The diagnostic delay, sometimes reaching 12 years, reveals the complexity of this disease and the urgent need for effective therapeutic solutions. This prolonged diagnostic wandering worsens the impact on quality of life and compromises the chances of preserving fertility.
Clinical illustration: A 25-year-old patient presents with severe dysmenorrhoea since adolescence, having seen multiple practitioners without a precise diagnosis. The personal and professional impact becomes disabling, requiring immediate holistic care.
Limits of conventional approaches
Conventional treatments focus mainly on symptomatic management with painkillers and hormonal treatments, often associated with side effects that limit long-term therapeutic adherence.
This purely symptomatic approach does not meet your patients’ growing expectations for more holistic, personalised solutions. The emergence of Nutriend partially fills this therapeutic gap.
Key points:
- Conventional treatments have limits in terms of effectiveness and tolerability
- Patients are expressing growing demand for integrative approaches
Therapeutic innovation: the polymetallic complex
Nutriend’s mechanism of action
Nutriend is based on an innovative polymetallic complex developed by Nutrilab, a brand specialising in ethical solutions for poorly treated conditions. This approach using natural trace elements acts directly on dysfunctional endometrial cells.
The mechanism of action targets the specific cellular processes of endometriosis, offering a causal approach rather than a purely symptomatic one. This innovation opens up new therapeutic possibilities for your patients who are refractory to conventional treatments.
3-step micro-protocol for assessing Nutriend:
- Assess the symptom severity and functional impact of the endometriosis
- Check compatibility with current treatments (hormonal, fertility)
- Plan a 4-month efficacy follow-up using standardised pain criteria
Clinical efficacy data
Clinical studies demonstrate a reduction of 66% in pain in 91% of patients after 4 months of use, compared with only 26% in the placebo group. These clinically significant results position Nutriend as a credible therapeutic option.
This documented efficacy allows you to offer Nutriend on a solid scientific basis, strengthening your credibility with patients who are often sceptical after multiple therapeutic failures.
ParameterNutriendPlaceboPain reduction66%26%Responder rate91%Not specifiedAssessment period4 months4 months
Key points:
- Nutriend’s efficacy rests on controlled, significant clinical data
- The high responder rate suggests broad-spectrum efficacy
Practical applications and therapeutic compatibility
Integration into care pathways
Nutriend’s compatibility with other medical treatments, including fertility treatments, makes it easier to integrate into your existing protocols. This therapeutic flexibility avoids treatment interruptions and optimises overall care.
The absence of significant documented side effects strengthens the acceptability of this therapeutic option, particularly in patients who cannot tolerate conventional hormonal treatments.
Preventive approach in young women
Nutriend also shows preventive potential in young girls with severe menstrual pain, a population at risk of developing endometriosis. This early application could modify the natural history of the disease.
This preventive dimension widens your therapeutic indications and reflects a logic of anticipatory medicine, particularly valued in contemporary gynaecological practice.
Key points:
- Therapeutic compatibility makes integration into existing protocols easier
- The preventive approach opens up new possibilities in young women at risk
5 habits to build in from tomorrow
Immediately optimise your management of endometriosis with these Nutriend strategies:
Systematically offer Nutriend to endometriosis patients who have failed or cannot tolerate conventional treatments. This natural option often meets their unmet therapeutic expectations.
Assess the preventive potential in adolescents with a family history of severe dysmenorrhoea or suggestive history. This early intervention can favourably change the course of the disease.
Rigorously document pain-relief efficacy using standardised scales before and after treatment. This objective measurement strengthens your clinical assessment and guides therapeutic adjustments.
Inform your patients about the compatibility with assisted reproduction pathways. This reassurance supports adherence and avoids harmful treatment interruptions.
Build your Nutrilab network to optimise access and follow-up for your patients. This brand-practitioner collaboration enriches your expertise in therapeutic innovations.
Essential points for your practice
Nutriend represents a significant therapeutic advance in the management of endometriosis, a complex condition affecting millions of women. The documented clinical efficacy data justify its integration into your therapeutic arsenal.
Compatibility with existing treatments and the absence of major side effects make it easier for your patients to adopt, as they are often seeking alternatives to conventional approaches. The preventive potential further widens the possibilities for use.
These tools extend Simplycure’s commitment to accessible, rigorous and personalised preventive medicine. Integrating Nutriend into your practice perfectly illustrates this innovative approach, centred on the real needs of your patients.
Frequently asked questions
How do you start Nutriend treatment in an endometriosis patient?
First assess symptom severity and functional impact. Check compatibility with current treatments and plan a 4-month efficacy follow-up. The absence of major contraindications makes it easier to start.
Can Nutriend be used together with hormonal treatment?
Yes, compatibility with conventional medical treatments, including hormonal ones, is a major advantage of Nutriend. This combination can enhance overall efficacy without increasing risks.
When should Nutriend’s efficacy be assessed?
The optimal assessment point is 4 months of treatment, based on available clinical data. However, improvement may be noticeable earlier in some responding patients.
Is preventive treatment with Nutriend justified in adolescents?
In adolescents with severe menstrual pain and risk factors for endometriosis, the preventive approach may be justified. Individual assessment of the benefit-risk balance remains essential.
How should you explain Nutriend’s mechanism of action to patients?
Present Nutriend as a complex of natural trace elements acting directly on dysfunctional endometrial cells. This causal approach differs from purely symptomatic treatments and explains its documented efficacy.
